RNAZ

TransCode Therapeutics, Inc. (RNAZ) is a pioneering biopharmaceutical company based in Boston, Massachusetts, dedicated to the development and commercialization of innovative therapies for metastatic diseases. Utilizing its proprietary technologies, TransCode aims to address critical unmet medical needs in oncology, particularly by enhancing the efficacy of existing cancer treatments. With a strong focus on advancing cancer care, the company is well-positioned to make significant contributions to the evolving landscape of cancer therapeutics, appealing to institutional investors seeking opportunities in the biopharmaceutical sector.